Pathology Portal

“Signatures of Mutational Processes in Human Cancer”

Not yet rated

Prof Mike Stratton is the Director of the Wellcome Sanger Institute and Chief Executive Officer of the Wellcome Genome Campus. His primary research interests have been in the genetics of cancer. Mike mapped and identified the major high-risk breast cancer susceptibility gene BRCA2 and subsequently a series of moderate-risk breast cancer and other cancer susceptibility genes. Prof Mike Stratton initiated the Cancer Genome Project at the Wellcome Sanger Institute which conducts systematic genome-wide searches for somatic mutations in human cancer. Through these studies he discovered somatic mutations of the BRAF gene in malignant melanoma and several other mutated cancer genes in lung, renal, breast and other cancers. He has described the basic patterns of somatic mutation in cancer genomes revealing underlying DNA mutational and repair processes.

Resource details

Contributed by: Pathology Portal
Authored by: Prof Mike Stratton, Wellcome Sanger Institute, Director of the Wellcome Sanger Institute and Chief Executive Officer of the Wellcome Genome Campus
Licence: More information on licences
Last updated: 20 October 2022
First contributed: 20 October 2022
Audience access level: Full user

Ratings

0 ratings

Not yet rated
5 star
0%
4 star
0%
3 star
0%
2 star
0%
1 star
0%
Report an issue with this resource

You may report a resource, for example, if there is an issue with copyright infringement, breach of personal data, factual inaccuracies, typing errors or safety concerns. The type of issue will determine whether the resource is immediately removed from the platform or if the contributor is asked to make amendments. You can report a resource from the resource information page or by contacting the Learning Hub support team.

You can contact the Learning Hub support team by completing the support form or if you have a general enquiry you can email enquiries@learninghub.nhs.uk.